To assess the effects of neoadjuvant treatments in adults with American Joint Committee on Cancer (AJCC) stage III or stage IV melanoma.
This is a protocol.
Neoadjuvant treatment for malignant and metastatic cutaneous melanoma
You may also be interested in:
- Systemic treatments (tablets or injections) taken for metastatic melanoma (expanded from its starting point to other parts of the body)
- Interferon for the treatment of melanoma patients after surgical removal of their tumour
- Surgical excision margins for primary cutaneous melanoma
- Screening for malignant melanoma (a type of skin cancer)
- Currently there is no clear evidence that cholesterol drugs reduce melanoma risk.
Health topics: